NCT03576651View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

March 24, 2018

Primary Completion Date

September 17, 2018

Study Completion Date

December 13, 2019

Conditions
Healthy Male Subjects
Interventions
BIOLOGICAL

JHL1149

Each patient may receive single dose of JHL1149 1mg/kg by intravenous infusion

BIOLOGICAL

Bevacizumab

Each patient may receive single dose of Avastin 1mg/kg by intravenous infusion

BIOLOGICAL

Bevacizumab

Each patient may receive single dose of Avastin 1mg/kg by intravenous infusion

Trial Locations (1)

1336

MHAT Lyulin EAD, Sofia

Sponsors

Lead Sponsor

JHL Biotech, Inc.
All Listed Sponsors
lead

JHL Biotech, Inc.

INDUSTRY